1. Home
  2. MD vs APLT Comparison

MD vs APLT Comparison

Compare MD & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

HOLD

Current Price

$22.00

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.13

Market Cap

18.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MD
APLT
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
18.0M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MD
APLT
Price
$22.00
$0.13
Analyst Decision
Hold
Hold
Analyst Count
4
3
Target Price
$21.00
$1.25
AVG Volume (30 Days)
1.2M
8.6M
Earning Date
11-03-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$1,922,442,000.00
$1,000,000.00
Revenue This Year
N/A
$124.18
Revenue Next Year
$2.70
$66.67
P/E Ratio
$11.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.84
$0.10
52 Week High
$24.99
$1.50

Technical Indicators

Market Signals
Indicator
MD
APLT
Relative Strength Index (RSI) 49.64 26.92
Support Level $21.41 $0.10
Resistance Level $22.68 $0.13
Average True Range (ATR) 0.74 0.02
MACD -0.22 0.02
Stochastic Oscillator 30.93 15.95

Price Performance

Historical Comparison
MD
APLT

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: